共 50 条
Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes
被引:28
作者:
Pang, Huiwen
[1
]
Huang, Xiangquan
[1
]
Xu, Zhi Ping
[1
]
Chen, Chen
[2
]
Han, Felicity Y.
[1
]
机构:
[1] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia
[2] Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld, Australia
关键词:
Oral insulin;
Poly(lactic co-glycolic acid) (PLGA);
Biological barriers;
Mucus;
Epithelium;
Gastrointestinal tract (GIT);
CELL-PENETRATING PEPTIDES;
DRUG-DELIVERY;
POLYMERIC NANOPARTICLES;
INTRACELLULAR FATE;
IN-VITRO;
MUCUS;
CHITOSAN;
SECRETION;
PEG;
ABSORPTION;
D O I:
10.1016/j.drudis.2022.103393
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Currently, the only practical way to treat type 1 and advanced insulin-dependent type 2 diabetes mellitus (T1/2DM) is the frequent subcutaneous injection of insulin, which is significantly different physiologically from endogenous insulin secretion from pancreatic islets and can lead to hyperinsu-linemia, pain, and infection in patients with poor compliance. Hence, oral insulin delivery has been actively pursued to revolutionize the treatment of insulin-dependent diabetes. In this review, we provide an overview of recent progress in developing poly(lactic co-glycolic acid) (PLGA) nanoparticles (NPs) for oral insulin delivery. Different strategies for insulin-loaded PLGA NPs to achieve normo-glycemic effects are discussed. Finally, challenges and future perspectives of PLGA NPs for oral insulin delivery are put forward.
引用
收藏
页码:14 / 14
页数:1
相关论文
共 50 条